tru Independence’s Evolus EOLS Stock Holding History

tru Independence’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,382	Closed	-$7	–	486
2020 Q2	$7	Hold	1,382	–	–	﹤0.01%	646
2020 Q1	$6	Hold	1,382	–	–	﹤0.01%	497
2019 Q4	$6K	Buy	+1,382	New	+$19.5K	﹤0.01%	638

Other funds holding EOLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

tru Independence's EOLS Position: Q3 2020 in Review

tru Independence sold out of Evolus (EOLS) in Q3 2020, closing a stake of 1,382 shares — an estimated $7 sold.

tru Independence first reported a position in EOLS in Q4 2019 and held it in 3 quarters. The position peaked at $6K in Q4 2019. 87 funds tracked by Wall St. Rank hold EOLS as of Q3 2020.

tru Independence reported no remaining Evolus position as of Q3 2020 after selling out during the quarter.
tru Independence sold 1,382 Evolus shares in Q3 2020, an estimated $7.
tru Independence first reported a position in Evolus in Q4 2019 and held it in 3 quarters.
tru Independence's Evolus position peaked at $6K in Q4 2019.
87 funds tracked by Wall St. Rank held Evolus as of Q3 2020.

Based on tru Independence's 13F filing for Q3 2020, filed 19 Nov 2020.